Tingyu Huang

Title: Innovations of Tingyu Huang in Pharmaceutical Development

Introduction

Tingyu Huang is a notable inventor based in Zhongshan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at treating neuroinflammation-related diseases. His work is characterized by a focus on innovative hybrid compounds that combine existing medications for enhanced therapeutic effects.

Latest Patents

Huang holds a patent for "Butylphthalide-telmisartan hybrids, preparation method and application thereof." This invention discloses a butylphthalide-telmisartan heterocomplex, along with its preparation method and applications. Specifically, it relates to an optically active ring-opening butylphthalide-telmisartan heterocomplex, or a pharmaceutically acceptable salt or ester thereof. The patent outlines a pharmaceutical composition containing these compounds and emphasizes their application in the prevention and treatment of various neuroinflammation-related diseases, including ischemic stroke, Alzheimer's disease, brain trauma, Parkinson's disease, multiple sclerosis, and depression. Huang's innovative approach aims to provide new therapeutic options for patients suffering from these conditions.

Career Highlights

Tingyu Huang is associated with Guangdong Longfu Medicine Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on the pharmaceutical industry, particularly in the realm of neurodegenerative diseases. Huang's dedication to innovation is evident in his patent, which reflects a commitment to improving patient outcomes through scientific advancement.

Collaborations

Huang collaborates with esteemed colleagues, including Jinxiang Deng and Wenbin Zeng, who contribute to his research initiatives. Their combined expertise enhances the development of new pharmaceutical solutions and fosters a collaborative environment for innovation.

Conclusion

Tingyu Huang's contributions to pharmaceutical innovation, particularly through his patent on butylphthalide-telmisartan hybrids, highlight the importance of interdisciplinary collaboration in addressing complex medical challenges. His work exemplifies the potential of innovative compounds to transform treatment options for neuroinflammation-related diseases.